Li Qiaoqiao, Cao Fuli, Gao Xueping, Xu Yuan, Li Bo, Hu Tianyang
Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, No. 76 Linjiang Road, Chongqing, 400010, China.
Department of Geriatrics and Special Service Medicine, First Affiliated Hospital of Army Medical University (Southwest Hospital), Chongqing, 400038, China.
Glob Heart. 2024 Dec 5;19(1):91. doi: 10.5334/gh.1373. eCollection 2024.
Peripheral artery disease (PAD) is a manifestation of systemic atherosclerosis that can result in limb pain, disability, or mortality. Notably, diabetes mellitus (DM) stands out as one of the most significant risk factors for the development of PAD. Compared to individuals with PAD but no DM, those with concurrent DM and PAD (DM-PAD, diabetes mellitus-peripheral artery disease) face a seven-fold higher risk of critical limb ischemia and a five-fold higher risk of amputation. However, the pathogenic factors and effective therapeutic targets for DM-PAD still remain elusive.
To identify candidate hub genes and develop insights into the pathogenesis of DM-PAD, we employed a comprehensive approach encompassing two-sample Mendelian Randomization (two-sample MR), summary data-based Mendelian randomization (SMR), and Bayesian colocalization (COLOC) methods. These methodologies facilitated the integration of summary-level data derived from genome-wide association studies of DM-PAD with expression quantitative trait locus (eQTLs) studies conducted on blood samples.
, and were found to have passed two-sample MR and SMR analyses, indicating their status as hub genes associated with DM-PAD through mechanisms involving not linkage but rather causality. The COLOC analysis provided strong evidence suggesting that and the DM-PAD trait were influenced by the common causal variant rs1150948.
Our study has pinpointed several crucial genes (, and ), notably the gene, as potential regulators in the pathogenesis of DM-PAD. These discoveries hold promises for shedding light on the underlying mechanisms and novel targets of the disease in future research.
外周动脉疾病(PAD)是全身动脉粥样硬化的一种表现,可导致肢体疼痛、残疾或死亡。值得注意的是,糖尿病(DM)是PAD发生的最重要危险因素之一。与患有PAD但无DM的个体相比,同时患有DM和PAD(DM-PAD,糖尿病合并外周动脉疾病)的个体发生严重肢体缺血的风险高7倍,截肢风险高5倍。然而,DM-PAD的致病因素和有效的治疗靶点仍然不清楚。
为了识别候选枢纽基因并深入了解DM-PAD的发病机制,我们采用了一种综合方法,包括两样本孟德尔随机化(两样本MR)、基于汇总数据的孟德尔随机化(SMR)和贝叶斯共定位(COLOC)方法。这些方法有助于将来自DM-PAD全基因组关联研究的汇总水平数据与对血液样本进行的表达定量性状位点(eQTL)研究相结合。
发现[具体基因1]、[具体基因2]和[具体基因3]通过涉及非连锁而是因果关系的机制,通过了两样本MR和SMR分析,表明它们作为与DM-PAD相关的枢纽基因的地位。COLOC分析提供了强有力的证据,表明[具体基因1]和DM-PAD性状受共同因果变异rs1150948的影响。
我们的研究确定了几个关键基因([具体基因1]、[具体基因2]和[具体基因3]),特别是[具体基因]基因,作为DM-PAD发病机制中的潜在调节因子。这些发现有望为未来研究揭示该疾病的潜在机制和新靶点。